ATM and melanoma: This study aimed to assess the impact of deleterious <i>ATM</i> variants on homologous recombination deficiency (HRD) and response to PARP inhibitors (PARPi) in melanoma patients, using a cell line established from melanoma tissue of a patient carrying the c.5979_5983del germline <i>ATM</i> variant.